iDEL Therapeutics

Raised $10.4M in a Seed round, announced 17 March 2026.

Latest round SeedCountry GermanySector Health

Round

Funds lead oncology programs toward clinical evaluation.

Amount: $10.4M
Stage: Seed
Announced: 17 March 2026
Lead: BiomedVC
Other investors: NRW.BANK, Gründerfonds Ruhr, KHAN Technology Transfer Fund II
Use of funds: Funds lead oncology programs toward clinical evaluation.
Checked: Matched to an official SEC filing
Sources: iDEL Therapeutics raises €9M for cytosolic cancer drug delivery biospace.com
iDEL Therapeutics raises €9M for cytosolic cancer drug delivery pulse2.com

Synthetic shuttle platform delivering cancer drugs into the cell cytosol

How much has iDEL Therapeutics raised?

iDEL Therapeutics raised $10.4M in a Seed round, announced on 17 March 2026.

Who invested in iDEL Therapeutics?

BiomedVC led. Investors include BiomedVC, NRW.BANK, Gründerfonds Ruhr and KHAN Technology Transfer Fund II.